Trademark Attorney / Law Firm

Veronica Ashley Bowen – Trademark Portfolio

Veronica Ashley Bowen specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 30 (Staple Foods) along with 2 other Nice Classification classes. Filing activity spans from 2022 to 2024. Currently, 1 trademark is registered.

2 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Veronica Ashley Bowen's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademark applications has Veronica Ashley Bowen filed?

Veronica Ashley Bowen has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 abandoned.

What trademark classes does Veronica Ashley Bowen specialize in?

Veronica Ashley Bowen has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has Veronica Ashley Bowen been filing trademarks?

Veronica Ashley Bowen's trademark filing history with the USPTO spans from 2022 to 2024, covering 2 years of trademark practice. During this period, Veronica Ashley Bowen has handled 2 trademark applications.

What is Veronica Ashley Bowen's trademark registration success rate?

Veronica Ashley Bowen has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.